Home Newsfeeds HilleVax Q2 EPS $(2.03) Down From $(0.34) YoY

HilleVax Q2 EPS $(2.03) Down From $(0.34) YoY

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(2.03) per share. This is a 497.06 percent decrease over losses of $(0.34) per share from the same period last year.

byBenzinga Newsdesk

August 10, 2022

1 minute read

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(2.03) per share. This is a 497.06 percent decrease over losses of $(0.34) per share from the same period last year.

Why Teva Pharmaceuticals Stock Is Soaring After Hours

By Adam Eckert

July 26, 5:40 PM

Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.

TEVA

News

Acer Therapeutics and Relief Therapeutics Announce That The China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

By Bill Haddad

July 8, 8:34 AM

Acer Therapeutics Inc. (NASDAQ:ACER) (Acer) and its collaboration partner, RELIEF THERAPEUTICS Holding SA ((SIX: RLF, OTCQB:RLFTF, RLFTY)) (Relief), today announced that the China National Intellectual Property

ACER

Fed’s Bostic Says I’m Hopeful We Are On The Right Track; Says We Are Starting To See Positive Signs; Says We Are Not There Yet; Says Restrictive Is 3.5% -3.75% Hopeful To Get There By Year End

By Benzinga Newsdesk

August 26, 8:46 AM

-Reuters

SPY

News

Limble Announces Integration With Samsara To Improve Predictive Maintenance For Fleet Management Teams

By Benzinga Newsdesk

November 14, 10:19 AM

Mutual customers will benefit from new automated capabilities and improved maintenance tracking and reportingLEHI, Utah, Nov. 14, 2023 /PRNewswire/ -- Limble, the leading provider of modern computerized maintenance

IOT

HilleVax Q2 EPS $(2.03) Down From $(0.34) YoY

Related Posts

Why Teva Pharmaceuticals Stock Is Soaring After Hours

Acer Therapeutics and Relief Therapeutics Announce That The China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

Fed’s Bostic Says I’m Hopeful We Are On The Right Track; Says We Are Starting To See Positive Signs; Says We Are Not There Yet; Says Restrictive Is 3.5% -3.75% Hopeful To Get There By Year End

Limble Announces Integration With Samsara To Improve Predictive Maintenance For Fleet Management Teams